COVID-19haematological malignancyautoimmune/inflammatory diseasesimmunosuppressive therapyWestern Sydney Local Health District Human Research Ethics Committee
…nths will be randomised 1:1 to either receive a fourth post-BMT COVID-19 booster at 9 or 15 months post-transplant. The primary outcome …